MedPath
HSA Approval

STORILAT 200 TABLET 200 mg

SIN05583P

STORILAT 200 TABLET 200 mg

STORILAT 200 TABLET 200 mg

February 18, 1991

GOLDPLUS UNIVERSAL PTE LTD

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGOLDPLUS UNIVERSAL PTE LTD
Licence HolderGOLDPLUS UNIVERSAL PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

N03AF01

carbamazepine

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

REMEDICA LTD

Active Ingredients

CARBAMAZEPINE

200 mg

Carbamazepine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

STORILAT 200 TABLET 200 mg - HSA Approval | MedPath